Article (Scientific journals)
Recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic - FRANCOGYN group for the CNGOF.
Akladios, Cherif; Azais, Henri; Ballester, Marcos et al.
2020In Journal of Gynecology Obstetrics and Human Reproduction, 49 (6), p. 101729
Peer Reviewed verified by ORBi


Full Text
Publisher postprint (332.64 kB)

All documents in ORBi are protected by a user license.

Send to


Keywords :
Betacoronavirus; Chemotherapy, Adjuvant; Coronavirus Infections/complications/epidemiology/prevention & control; Endometrial Neoplasms/pathology/surgery; Female; France; Genital Neoplasms, Female/complications/pathology/surgery/therapy; Gynecology; Humans; Interdisciplinary Communication; Obstetrics; Ovarian Neoplasms/drug therapy/pathology; Pandemics/prevention & control; Pneumonia, Viral/complications/epidemiology/prevention & control; Receptors, Lymphocyte Homing; Risk; Societies, Medical; Trophoblastic Neoplasms/drug therapy; Uterine Cervical Neoplasms/therapy; Vaginal Neoplasms/therapy; Vulvar Neoplasms/surgery; COVID-19; Guideline; Gynaecological cancer; Management
Abstract :
[en] INTRODUCTION: In the context of the COVID-19 pandemic, specific recommendations are required for the management of patients with gynecologic cancer. MATERIALS AND METHOD: The FRANCOGYN group of the National College of French Gynecologists and Obstetricians (CNGOF) convened to develop recommendations based on the consensus conference model. RESULTS: If a patient with a gynecologic cancer presents with COVID-19, surgical management should be postponed for at least 15 days. For cervical cancer, radiotherapy and concomitant radiochemotherapy could replace surgery as first-line treatment and the value of lymph node staging should be reviewed on a case-by-case basis. For advanced ovarian cancers, neoadjuvant chemotherapy should be preferred over primary cytoreduction surgery. It is legitimate not to perform hyperthermic intraperitoneal chemotherapy during the COVID-19 pandemic. For patients who are scheduled to undergo interval surgery, chemotherapy can be continued and surgery performed after 6 cycles. For patients with early stage endometrial cancer of low and intermediate preoperative ESMO risk, hysterectomy with bilateral adnexectomy combined with a sentinel lymph node procedure is recommended. Surgery can be postponed for 1-2 months in low-risk endometrial cancers (FIGO Ia stage on MRI and grade 1-2 endometrioid cancer on endometrial biopsy). For patients of high ESMO risk, the MSKCC algorithm (combining PET-CT and sentinel lymph node biopsy) should be applied to avoid pelvic and lumbar-aortic lymphadenectomy. CONCLUSION: During the COVID-19 pandemic, management of a patient with cancer should be adapted to limit the risks associated with the virus without incurring loss of chance.
Disciplines :
Author, co-author :
Akladios, Cherif
Azais, Henri
Ballester, Marcos
Bendifallah, Sofiane
Bolze, Pierre-Adrien
Bourdel, Nicolas
Bricou, Alexandre
Canlorbe, Geoffroy
Carcopino, Xavier
Chauvet, Pauline
Collinet, Pierre
Coutant, Charles
Dabi, Yohann
Dion, Ludivine
Gauthier, Tristan
Graesslin, Olivier
Huchon, Cyrille
Koskas, Martin
Kridelka, Frédéric ;  Université de Liège - ULiège > Département des sciences cliniques > Gynécologie-Obstétrique
Lavoue, Vincent
Lecointre, Lise
Mezzadri, Matthieu
Mimoun, Camille
Ouldamer, Lobna
Raimond, Emilie
Touboul, Cyril
More authors (16 more) Less
Language :
Title :
Recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic - FRANCOGYN group for the CNGOF.
Publication date :
Journal title :
Journal of Gynecology Obstetrics and Human Reproduction
Publisher :
Elsevier Masson
Volume :
Issue :
Pages :
Peer reviewed :
Peer Reviewed verified by ORBi
Commentary :
Copyright © 2020 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.
Available on ORBi :
since 30 October 2020


Number of views
119 (3 by ULiège)
Number of downloads
46 (2 by ULiège)

Scopus citations®
Scopus citations®
without self-citations


Similar publications

Contact ORBi